Anavex Life Sciences Corp (AVXL)

[falconer66a]

Thank you. Good thinking!

Nidan, I was lax in considering the wider application this new digital technology, which accurately and precisely detects Alzheimer’s and Parkinson’s Diseases biomarkers. I was looking ahead to when blarcamesine and Anavex 3-71 become available for clinical uses; to treat and/or prevent those CNS diseases. Good enough; but not as good (at least right now) for the good purposes you proposed; to use the device to cheaply, quickly, and accurately determine the status of CNS disease biomarkers during clinical trials of Anavex molecules. So much better than existing biomarker analyses.

Yep, as you pointed out (thank you), the device could optimize the testing of Anavex molecules in patients in new Anavex clinical studies. Quick. Easy. Accurate. The clinical trial game changes. Instead of years; months.